Literature DB >> 11526606

Heart rate variability as an outcome measure for Thought Field Therapy in clinical practice.

M Pignotti1, M Steinberg.   

Abstract

The need for empirical, objective, clear, and practical outcome measures for therapy has long been recognized by clinicians and researchers. Pragmatic tools for objective determination of the efficacy of therapy have been scarce in clinical practice settings. Heart rate variability (HRV) is increasing in popularity for use in clinical settings as a measure of treatment success. Since HRV is stable and placebo-free, it has the potential to meet this need. Thirty-nine cases are presented from the clinical practices of the authors and three other clinicians where HRV was used as an outcome measure for Thought Field Therapy (TFT). The cases included TFT treatments which addressed a wide variety of problems including phobias, anxiety, trauma, depression, fatigue, attention deficit hyperactivity disorder, learning difficulties, compulsions, obsessions, eating disorders, anger, and physical pain. A lowering of subjective units of distress was in most cases related to an improvement in HRV. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11526606     DOI: 10.1002/jclp.1086

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  3 in total

1.  Sympathetic and parasympathetic responses to specific diversified adjustments to chiropractic vertebral subluxations of the cervical and thoracic spine.

Authors:  Arlene Welch; Ralph Boone
Journal:  J Chiropr Med       Date:  2008-09

Review 2.  Nociception monitoring tools using autonomic tone changes for intraoperative analgesic guidance in pediatric patients.

Authors:  Byung Gun Lim
Journal:  Anesth Pain Med (Seoul)       Date:  2019-10-31

3.  Biomedical Teleacupuncture between China and Austria Using Heart Rate Variability-Part 2: Patients with Depression.

Authors:  Gerhard Litscher; Guangyu Cheng; Lu Wang; Weiping Cheng; Hang Su; Qianqian Niu; Tianyu Zou; Yongyue Wang; Xiao Feng; Ingrid Gaischek; Zemin Sheng; Haixue Kuang
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-17       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.